Mass Spectrometry Analyses of Multicellular Tumor Spheroids

被引:19
作者
Acland, Mitchell [1 ,2 ]
Mittal, Parul [1 ,2 ]
Lokman, Noor A. [3 ]
Klingler-Hoffmann, Manuela [1 ,4 ]
Oehler, Martin K. [3 ,5 ]
Hoffmann, Peter [1 ,4 ]
机构
[1] Univ Adelaide, Sch Biol Sci, Adelaide Prote Ctr, Adelaide, SA, Australia
[2] Univ Adelaide, Inst Photon & Adv Sensing, Adelaide, SA, Australia
[3] Univ Adelaide, Robinson Res Inst, Sch Med, Discipline Obstet & Gynaecol, Adelaide, SA, Australia
[4] Univ South Australia, Future Ind Inst, Adelaide, SA, Australia
[5] Royal Adelaide Hosp, Dept Gynaecol Oncol, Adelaide, SA, Australia
关键词
cancer; drug resistance; mass spectrometry-LC-MS; MS; mass spectrometry-MALDI-TOF; multicellular tumor spheroids; ovarian cancer; 3-DIMENSIONAL CELL-CULTURE; HYDROPHILIC-INTERACTION CHROMATOGRAPHY; DRUG-DELIVERY SYSTEMS; OVARIAN-CANCER; PROTEOMIC ANALYSIS; PROTEIN EXPRESSION; DIFFERENT REGIONS; IN-VITRO; GENE-EXPRESSION; TISSUE-CULTURE;
D O I
10.1002/prca.201700124
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Multicellular tumor spheroids (MCTS) are a powerful biological in vitro model, which closely mimics the 3D structure of primary avascularized tumors. Mass spectrometry (MS) has established itself as a powerful analytical tool, not only to better understand and describe the complex structure of MCTS, but also to monitor their response to cancer therapeutics. The first part of this review focuses on traditional mass spectrometry approaches with an emphasis on elucidating the molecular characteristics of these structures. Then the mass spectrometry imaging (MSI) approaches used to obtain spatially defined information from MCTS is described. Finally the analysis of primary spheroids, such as those present in ovarian cancer, and the great potential that mass spectrometry analysis of these structures has for improved understanding of cancer progression and for personalized in vitro therapeutic testing is discussed.
引用
收藏
页数:13
相关论文
共 132 条
[1]   Mass spectrometry-based proteomics [J].
Aebersold, R ;
Mann, M .
NATURE, 2003, 422 (6928) :198-207
[2]   Models, mechanisms and clinical evidence for cancer dormancy [J].
Aguirre-Ghiso, Julio A. .
NATURE REVIEWS CANCER, 2007, 7 (11) :834-846
[3]   Proteomic and metabolic prediction of response to therapy in gastric cancer [J].
Aichler, Michaela ;
Luber, Birgit ;
Lordick, Florian ;
Walch, Axel .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (38) :13648-13657
[4]   Proteomics-based identification of biomarkers for predicting sensitivity to a PI3-kinase inhibitor in cancer [J].
Akashi, Tetsuyuki ;
Nishimura, Yumiko ;
Wakatabe, Rumi ;
Shiwa, Mieko ;
Yamori, Takao .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 352 (02) :514-521
[5]   Liposomal drug delivery systems: From concept to clinical applications [J].
Allen, Theresa M. ;
Cullis, Pieter R. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :36-48
[6]   HYDROPHILIC-INTERACTION CHROMATOGRAPHY OF COMPLEX CARBOHYDRATES [J].
ALPERT, AJ ;
SHUKLA, M ;
SHUKLA, AK ;
ZIESKE, LR ;
YUEN, SW ;
FERGUSON, MAJ ;
MEHLERT, A ;
PAULY, M ;
ORLANDO, R .
JOURNAL OF CHROMATOGRAPHY A, 1994, 676 (01) :191-202
[7]   HYDROPHILIC-INTERACTION CHROMATOGRAPHY FOR THE SEPARATION OF PEPTIDES, NUCLEIC-ACIDS AND OTHER POLAR COMPOUNDS [J].
ALPERT, AJ .
JOURNAL OF CHROMATOGRAPHY, 1990, 499 :177-196
[8]   Proteomics for discovery of candidate colorectal cancer biomarkers [J].
Alvarez-Chaver, Paula ;
Otero-Estevez, Olalla ;
Paez de la Cadena, Maria ;
Rodriguez-Berrocal, Francisco J. ;
Martinez-Zorzano, Vicenta S. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (14) :3804-3824
[9]  
[Anonymous], 2017, J R SOC INTERFACE
[10]   Three-Dimensional Cell Culture: A Breakthrough in Vivo [J].
Antoni, Delphine ;
Burckel, Helene ;
Josset, Elodie ;
Noel, Georges .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2015, 16 (03) :5517-5527